Key result
Cardiopulmonary exercise testing in patients with high-risk cardiovascular diseases was safe, with a major adverse event rate of 0.16% and no fatal events.
Why the study?
Is cardiopulmonary exercise testing safe in patients with high-risk cardiovascular diseases?
Population
4,250 unique patients with high-risk cardiac diseases including congestive heart failure, hypertrophic…
Design
Cohort
Follow-up
During stress testing
Authors
Loading...
Supports CPX safety in high-risk patients; leaves open prospective confirmation before broader adoption.
Observational (n=4,250)
No
Is cardiopulmonary exercise testing safe in patients with high-risk cardiovascular diseases?
Cardiopulmonary exercise testing is a safe procedure with a very low adverse event rate (0.16%) even in patients with high-risk cardiovascular diagnoses.
Skalski et al. (2012) conducted an observational in High-risk cardiovascular diseases (n=4,250). Cardiopulmonary exercise testing (CPX) was evaluated on Major adverse event during stress testing. Cardiopulmonary exercise testing in patients with high-risk cardiovascular diseases was safe, with a major adverse event rate of 0.16% and no fatal events.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: